Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489053 · ClinicalTrials.gov registry record · NA
Optimizing Functional Recovery After Breast Cancer Treatment
A NA study, sponsored by MGH Institute of Health Professions.
- Not yet
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT07489053: Clinical Trial NA study, sponsored by MGH Institute of Health Professions.
NCT07489053 is a NA study that has not yet begun recruiting, run by MGH Institute of Health Professions. The registered enrollment target is 352 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07489053, a NA study, has not yet begun recruiting, sponsored by MGH Institute of Health Professions.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living? Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.
Primary Outcome
Scores range from 8 to 40, with higher values representing greater satisfaction with ability to participate in social roles and activities.
Interventions
- BEHAVIORAL Individually tailored education and guided application to promote activity participation
- BEHAVIORAL Individually tailored guided application
- BEHAVIORAL Individually tailored education
- BEHAVIORAL Priority elicitation
- BEHAVIORAL Static education and guided application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
What is known before NCT07489053 opens enrollment
NCT07489053 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 5 interventions - of which Individually tailored education and guided application to promote activity participation is the first listed.
NCT07489053 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07489053 about?
NCT07489053 is a clinical study titled "Optimizing Functional Recovery After Breast Cancer Treatment". The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention ...
What is the current status of trial NCT07489053?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2027-01-01. Estimated completion is 2030-09-30.
What interventions are being tested in trial NCT07489053?
The interventions under investigation include: Individually tailored education and guided application to promote activity participation (BEHAVIORAL), Individually tailored guided application (BEHAVIORAL), Individually tailored education (BEHAVIORAL), Priority elicitation (BEHAVIORAL), Static education and guided application (BEHAVIORAL).
Who is sponsoring clinical trial NCT07489053?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07489053's enrollment target sits among peer trials
352 292nd of 2000 higher than 1,709 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI